The pitch
Elizabeth Holmes founded Theranos in 2003, aged 19, with the promise of a device — the Edison — that could run hundreds of tests on a finger-prick of blood. The story was compelling: cheaper, faster, more accessible diagnostics, with a board that included George Shultz and Henry Kissinger.
By 2014 the company was valued at around $9 billion and Holmes was the youngest self-made female billionaire on paper. The published, peer-reviewed evidence for the technology was essentially absent.
The collapse
In October 2015, John Carreyrou reported in the Wall Street Journal that the Edison devices ran only a handful of tests, that most were performed on modified commercial analysers, and that accuracy problems had been concealed.
Regulators found the labs deficient; the Centers for Medicare & Medicaid Services revoked the lab's certification; Walgreens ended its partnership and closed its Theranos wellness centres. In 2018 the SEC charged Holmes and the company's president with fraud, and Theranos dissolved.
Documented, not alleged. The SEC's complaint, the criminal conviction and the company's own admissions establish the fraud. Holmes was convicted on four counts in January 2022 and sentenced to 11 years; Ramesh Balwani was convicted separately.
The failure was technoscientific, not just financial. Microfluidics at that scale is genuinely hard: small samples dilute, haemolysis distorts results, and validating a new assay against the standard is a long process. The company skipped that work and claimed the result.
Institutions failed around it. A board of statesmen with no relevant expertise, journalists who amplified the pitch, and investors who did not ask for data. The lesson is about diligence, not only about one founder.
Why it is in the archive
Because it is the cleanest modern example of a claim that was testable and was not tested — the opposite of the archive's conspiracy material, where the problem is usually that nothing can be tested.
The comparison worth making is with the proven plots: in both cases, the accusation was specific, the evidence was documentary, and the resolution came through courts and regulators rather than argument.
Sources for this page
- U.S. SEC (2018), charges against Theranos, Holmes and Balwaniwww.sec.gov
- Wall Street Journal, John Carreyrou's investigation (2015)www.wsj.com
- U.S. DOJ, the Theranos prosecutionswww.justice.gov
- Wikipedia, “Theranos” — timeline, regulation and trialen.wikipedia.org